Randall C. Schatzman - 31 Dec 2023 Form 5 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Executive Officer, Director
Signature
/s/ William P. Quinn, Attorney-in-Fact
Issuer symbol
BOLT
Transactions as of
31 Dec 2023
Net transactions value
+$4,909
Form type
5
Filing time
06 Feb 2024, 13:08:17 UTC
Previous filing
28 Feb 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLT Common Stock Purchase $2,954 +2,500 +32% $1.18 10,359 06 Jun 2023 Direct F1
transaction BOLT Common Stock Purchase $1,955 +2,500 +24% $0.7820 12,859 06 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the issuer's Employee Stock Purchase Plan.